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Abstract
The klotho gene is considered to regulate the lifespan of animals including 
humans. The klotho mutant mouse, which has a defective klotho gene, 
shows many age-related disorders and has a short lifespan, around 2 months 
old; the overexpression of this gene in the normal wild-type mouse extends 
lifespan significantly. In klotho mutant mice, various organs/tissues have 
been analyzed extensively, especially with regard to the problem in ion 
homeostasis. However, the central nervous system (CNS) of this mutant 
mouse has not attracted as much attention, probably due to its protection 
from peripheral circumstances. Although it is suggested that some neurons 
in the CNS of klotho mice are degenerative, no distinct evidence has yet 
emerged. There are alterations in neurofilaments and microtubules with 
their constituent or associated proteins, and significant differences in the 
distribution and expression of these structures and proteins between wild-
type and mutant CNS. The expression of antiapoptotic and proapoptotic 
proteins were significantly changed in klotho mutant mice compared with 
wild-type mice. Lysosomes, lysosome-like profiles and synapse-related 
structures with their respective associated proteins were also altered in 
the mutant mice. Neuronal degeneration was evident in some restricted 
regions of the CNS, such as in the hippocampus. Gliofilaments in astro-
cytes and GFAP were drastically altered in density and expression, respec-
tively. These alterations in klotho mutant mouse CNS are similar to those 
in aged animals or humans, despite some differences between them, 
probably because of very early death of the mutant mice, which indicate 
that the mutant mice would be a valuable genetic model for multiple 
analyses on the aging of the CNS including the autonomic nervous sys-
tem. Prevention of neurodegeneration in the mutant mice with nutritional 
manipulation using antioxidants such as polyphenols is also discussed. 
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1. Introduction
The klotho gene, a senescence-related gene, was 
originally identified by insertional mutagenesis in 
a mouse strain and encodes a putative type I trans-
membrane protein, the klotho protein, composed of 
1014 amino acids in both mice and rats [1,2] and 
1012 amino acids in humans [1]. It has been consid-
ered a suppressor of phenotype for aging, because 
when the expression of this gene is suppressed 
in mice, these gene-suppressed mice, called klotho 
mutant mice, characteristically exhibit age-related 
syndromes/deteriorations, such as arteriosclerosis, 
osteoporosis, skin atrophy, infertility, thymic atrophy, 
pulmonary emphysema and growth arrest, even when 
they are still premature in stage around the age of 4 
weeks [1]. The lifespan of klotho mutant mice is ex-
tremely short; they generally die around 8 weeks of 
age. However, since klotho mutant mice do not show 
some phenotypes frequently seen in aged humans, 
such as cancer, cataract and brain atrophy including 
the deposition of amyloid or senile plaque [1,3,4], 
it remains unclear if these mutant mice are suitable 
as an animal model for human aging, especially for 
brain aging.
Although neuronal cell degeneration or death was 
suggested to occur in klotho mutant mice, especially 
in the hippocampus due to cognition impairment [3] 
or cerebellar Purkinje cells [1], no morphological sign 
for such deterioration has been demonstrated thus 
far. Klotho mutant mice show obviously lower motility 
with gait disturbance, as already indicated by Kuro-o 
et al [1], and when they do not move, when they are 
at rest, it is clear that their limbs, especially the pos-
terior ones, are flattened (Fig. 1). Such disturbance 
in the motor function of skeletal muscles strongly 
suggests that motor neurons, either in the pyramidal 
or extrapyramidal system, are impaired. Therefore, in 
addition to the hippocampal neurons, it is of interest 
to analyze the morphology of Purkinje cells and spinal 
cord anterior horn cells. These two kinds of neurons 
are motor in nature; Purkinje cells belong to the 
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Fig. 1 — (A) Differences in appearance between wild-type (+/+, left) and homozygous mutant (-/-, right) mice at the 
age of 6 weeks. These littermate mice are 1 week younger than those used for our present study. Compared with the 
wild-type mouse, the mutant mouse is already much smaller in size and has a less fine coat of hair. Their tail tips were 
cut for genotype analysis, as shown in B. (B) Mouse genomic DNA screened by PCR analysis with specific primers from 
wild-type (+/+), heterozygous (+/-) and homozygous mutant (-/-) mice. Amplified DNA from wild-type mice shows a 
single band at 815 bp and that from homozygous mutant mice at 491 bp, while that from heterozygous mice are at both 
bands. (C) Homogenized postnuclear supernatants (PNS), from wild-type (+/+) and mutant (-/-) CNS tissues, trans-
ferred onto gels, were stained with Coomassie brilliant blue. Protein concentrations from both PNS were identical in 
total, although some bands were different in density from each other. These samples were used for immunoblotting to 
compare the expression levels of the various proteins described in this review.
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extrapyramidal system while anterior horn cells are 
pyramidal, and they are both easy to identify and be 
compared among respective animals. Since the mu-
tant mice tend to be smaller as well as thinner after 
3 weeks of age, and such differences were signifi-
cantly distinct by the age of 6 weeks (Fig. 1A), many 
internal organs, such as the digestive system, must 
be disordered due partially to impairment of the au-
tonomic nervous system. However, it is complicated 
to analyze the relationship between the internal or-
gans and autonomic nervous system because of the 
involvement of the endocrine system, and so these 
points will not be discussed here.
2. Neurodegeneration with aging
The mechanism for neurodegeneration in the central 
nervous system (CNS) of klotho mutant mice has not 
extensively been analyzed, probably due to less mor-
phological as well as physiological alterations in the 
CNS when compared to other organs, such as kidney, 
artery, bone, lung, skin and genital organs [1], with 
particular attention being paid to ion homeostasis re-
lated to kidney or bone [5–7] or vascular/endothelial 
dysfunction [8,9]. This is despite the fact that the 
klotho gene is more highly expressed in the brain than 
in other organs, with the exception of the kidney 
which has the highest expression of this gene [1,10]. 
Age-associated degeneration of neurons is detectable 
in aged animals and also in many age-related neuro-
degenerative diseases, such as in Alzheimer’s and 
Parkinson’s diseases. Although the neurofibrillary tan-
gles composed of a kind of microtubule-associated 
protein (MAP), tau, and senile plaques/amyloid de-
posits, both of which are hallmarks for Alzheimer 
disease [11,12], are not visible in klotho mutant mice, 
the absence of these pathological alterations do not 
support the idea that the CNS of klotho mutant mice 
is not associated with aging, because the normal 
aged animals do not show such degenerative changes 
either. Our detailed analysis of the whole CNS of 
klotho mutant mice in comparison with their wild-type 
littermates by immunoblotting, immunohistochemi-
cal and electron microscopic techniques (shown in 
Figs. 1 and 2) have convincingly demonstrated that 
the CNS neurons in these mutant mice are not sim-
ply immature or undeveloped but aging in nature 
after having almost developed, showing distinctive 
signs of neuronal degeneration or cell death even 
in their premature condition at less than 2 months of 
age [13]. Neuronal and glial intracellular structures and 
the expression patterns of many proteins associated 
with cell degeneration/death [14,15] in these cells in 
the klotho mutant CNS are very similar to those seen 
in aged animals and also in some neurodegenerative 
diseases.
3. Relationship between aging and 
cytoskeletons in the CNS
From our morphological viewpoint, the most powerful 
evidence to support the idea that neurons in klotho 
mutant mice are aging but not immature in nature 
was due to the increase in neurofilaments (NFs) in 
the cell bodies of both Purkinje cells and spinal cord 
anterior horn cells (Fig. 2). If the animals are imma-
ture and not fully developed, few NFs would be visible 
in neuronal cell bodies, especially in Purkinje cells in 
which NFs are much less numerous than in the ax-
onal compartment [16]. Among the normal neuronal 
cytoskeletons, NFs are the most susceptible cyto-
skeleton associated with aging or neurodegenerative 
diseases; they are increased in density in most axonal 
compartments and sometimes also in other neuronal 
compartments, dendrites and cell bodies [15,17,18]. 
In addition to the increase in the distribution density 
of NFs in neuronal cell bodies, NFs were more nu-
merous in the axonal compartment in klotho mutant 
mice than in wild-type mice, as is also demonstrated 
in aged rats [19,20]. In general, the phosphorylation 
level of NF subunit proteins, especially of NF-H, be-
comes higher with age and in neurodegenerative con-
ditions [15,18]. The relative reduction in the amount 
of NF-M was reported in aged rats [19,20] and also in 
klotho mutant mice [21]. Thus, changes in NF struc-
tural profiles and in the nature of their subunit pro-
teins are critical for identifying neuronal aging or 
degeneration. Thus, these morphological and bio-
chemical alterations in NFs and their subunit proteins, 
respectively, observed in klotho mutant mice strongly 
suggest that the CNS tissue in these mice is aging or 
degenerating.
In addition to NFs, another neuronal cytoskeletons, 
i.e., microtubules and its constituent protein, tubulin, 
do not show any significant difference in distribution 
density in neurons including their cell bodies (Fig. 2) 
and in expression level between wild-type and klotho 
mutant mice. However, in Purkinje cell dendrites, 
which are occupied predominantly with microtubules 
with few NFs even in normal adult animals [16], there 
was a detectable morphological change in the organi-
zation of this cytoskeleton; microtubules were aligned 
significantly closer to each other in mutant than in 
wild-type mice. Although there is no report on the 
expression of a disease-related MAP, tau, in klotho 
mutant mice, we found that another MAP, i.e., MAP2, 
was reduced in expression and also in histological 
labeling density, especially in the cell bodies. Since 
the reduced expression of MAP2 has been indicated 
in SAMP10 mice, another animal model of accelerated 
brain aging [22], our result also supports that the CNS 
neurons in klotho mutant mice are aging in nature.
Moreover, gliofilaments in astrocytes and the 
expression of their constituent protein, GFAP, were 
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drastically increased in distribution density and ex-
pression level, respectively, in klotho mutant mice. 
Such changes in glial structures and protein expres-
sion [15] also strongly suggest that the CNS of klotho 
mutant mice is either degenerating or aging, but not 
immature in nature.
Therefore, the klotho mutant mouse is a good 
model for brain aging and more suitable for ana-
lyzing neurodegenerative alterations dependent on 
aging processes than other proposed animal mod-
els. Klotho mutant mice have very short longevity, 
meaning that the aging process progresses rapidly, 
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Fig. 2 — Electron micrographs of cerebellar Purkinje cells (A and B) and spinal cord anterior horn cells (C and D) from 
wild-type (A and C) and mutant (B and D) mice. Cyto skeletons, neurofilaments (NFs) and microtubules, in the cell 
bodies from these neurons were compared between wild-type and mutant mice. NFs (arrows) were few in number in 
wild-type mice (A and C), there were hardly any in the Purkinje cell (A), but were obvious in mutant mice (B and D), 
showing significant increase in the anterior horn cell (D). On the other hand, microtubules (arrowheads), which are 
much thicker (25 nm) than NFs (10 nm), were always conspicuous in both neurons from the respective mice. The in crease 
in the distribution density of NFs in klotho mice indicates that CNS neurons in the mutant mice tend to be more mature 
than the wild-type mice or aged after maturation, indicating clearly that the klotho mutant CNS neurons are not less 
mature in nature than wild-type mice. Scale, 0.5 mm.
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making it convenient to analyze or modify the lifespan 
of these animals in the lab with short experimental 
periods [23].
4. Possible rescue of neuronal 
degeneration and extension of 
lifespan with nutritional manipulation
The short-lived klotho mutant mice are defective in 
the klotho gene, resulting in the absence of the ex-
pression of the protein, and introduction of exoge-
nous klotho gene into these mutant mice improve or 
rescue their disordered phenotypes [1]. More impor-
tantly, overexpression of the klotho gene significantly 
extends the lifespan of wild-type normal mice [24]. 
Moreover, the klotho protein appears to be associated 
with removal of reactive oxygen species [25]. There-
fore, in addition to gene manipulation, nutritional/
pharmacological manipulations of klotho mutant mice
with some powerful antioxidants are expected to im-
prove or rescue, at least to some extent, age-related 
deteriorations, especially CNS neuronal disorders, in 
these animals. In klotho mutant mice, treatment with 
antioxidant vitamin, α-tocopherol, was reported to 
ameliorate cognition impairment, and prevent lipid 
peroxidation and apoptosis in the hippocampus, 
although there was no effect on their lifespan [3].
However, other antioxidants such as polyphenols, 
widely present in fruits/vegetables, had some neuro-
protective effects [26]. Among the polyphenols, res-
veratrol, rich in grapes and red wine, is known to 
increase longevity in short-lived animals, whose ex-
perimental data are much easier to interpret than in 
animals with relatively longer lifespans such as ro-
dents [23]. Resveratrol and also other polyphenols, 
such as green tea polyphenols, may reduce the de-
gree of impairment in neurodegenerative conditions 
such as Alzheimer’s and Parkinson’s diseases [27,28]. 
Interestingly, resveratrol is considered to be associ-
ated with caloric restriction, affecting neuronal en-
ergy homeostasis by the activation of AMP-activated 
kinase, a sensor of cellular energy levels [29]. In ad-
dition to the antioxidant function of both resveratrol 
[26] and klotho protein [25], the presumed energy-
related functions of resveratrol seem to be associated 
with reduction of insulin/insulin-like growth factor I 
signaling, which is also brought about by klotho pro-
tein, providing the possible common mechanism by 
which both chemicals delay aging by energy or caloric 
balance/regulation [24,29–31]. Taken together, nutri-
tional manipulation with various polyphenols (includ-
ing resveratrol and red wine extracts), which is much 
safer and more applicable to humans than genetic 
manipulation, could be expected to improve disor-
dered CNS morphology and function of klotho mu-
tant mice and also aged animals, including humans, 
resulting in lifespan extension without impairment of 
neuronal cognitive function.
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